Rats were maintained on a daily regimen involving a 2h opportunity to
take both water and a sweetened alcoholic beverage (12% ethanol, 0.25%
saccharin). After 3 weeks on this regimen, rats regularly take substa
ntial amounts of alcohol. After stabilization, injections of alpha(2)-
adrenergic antagonists were administered, 15 min before the opportunit
y to drink. Yohimbine and methoxyidazoxan dose relatedly decreased int
ake of alcoholic beverage and increased intake of water. In Experiment
2, a number of rats were taken off the daily regimen for 9 days, then
returned to it. Across the first 12 days of the reinstated daily regi
men, half the rats received placebo and half methoxyidazoxan. The grou
p receiving placebo rapidly returned to taking large amounts of alcoho
lic beverage while the group receiving methoxyidazoxan did not. In Exp
eriment 3, it was shown that a dose of methoxyidazoxan that decreased
intakes of alcoholic beverage did not decrease intakes of other palata
ble beverages. In Experiment 4, it was shown that yohimbine persistent
ly reduced intakes of alcoholic beverage with daily administration. Th
ese results indicate that alpha(2)-antagonists might be effective phar
maceutical adjuncts to other treatments for alcohol abuse and alcoholi
sm.